These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37487714)

  • 1. Relapse of neurosymptomatic cerebrospinal fluid HIV RNA escape.
    Chan TY; Marta M; Rackstraw S
    HIV Med; 2023 Nov; 24(11):1158-1163. PubMed ID: 37487714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series.
    Chan TY; De Zan V; Gregg A; Alagaratnam J; Gerevini S; Antinori A; D'Arminio Monforte A; Saracino A; Trunfio M; Everitt A; Rackstraw S; Marta M; Calcagno A; Cinque P; Winston A
    AIDS; 2021 Nov; 35(14):2341-2346. PubMed ID: 34127578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    Handoko R; Chan P; Jagodzinski L; Pinyakorn S; Ubolyam S; Phanuphak N; Sacdalan C; Kroon E; Dumrongpisutikul N; Paul R; Valcour V; Ananworanich J; Vasan S; Spudich S;
    AIDS; 2021 Apr; 35(5):777-782. PubMed ID: 33306551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
    Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
    AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
    Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
    J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid viral escape in HIV patients on antiretroviral therapy: A systematic review of reported cases.
    Nyondo GG; Njiro BJ; Bwire GM
    Rev Med Virol; 2024 May; 34(3):e2536. PubMed ID: 38578230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning from cerebrospinal fluid drug-resistant HIV escape-associated encephalitis: a case report.
    Kang J; Wang Z; Zhou Y; Wang W; Wen Y
    Virol J; 2023 Dec; 20(1):292. PubMed ID: 38072961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape.
    Ferretti F; De Zan V; Gerevini S; Turrini F; Boeri E; Gianotti N; Hasson H; Lazzarin A; Cinque P
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):522-528. PubMed ID: 32875516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
    Pérez-Valero I; Ellis R; Heaton R; Deutsch R; Franklin D; Clifford DB; Collier A; Gelman B; Marra C; McCutchan JA; Navis A; Sacktor N; Simpson D; Grant I; Letendre S
    AIDS; 2019 Mar; 33(3):475-481. PubMed ID: 30702516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
    Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL;
    Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid virology in people with HIV.
    Henderson M; Pepper N; Bawa M; Muir D; Everitt A; Mackie NE; Winston A
    HIV Med; 2023 Jul; 24(7):838-844. PubMed ID: 36895097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid HIV RNA in persons living with HIV.
    Di Carlofelice M; Everitt A; Muir D; Winston A
    HIV Med; 2018 May; 19(5):365-368. PubMed ID: 29368400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
    Edén A; Fuchs D; Hagberg L; Nilsson S; Spudich S; Svennerholm B; Price RW; Gisslén M
    J Infect Dis; 2010 Dec; 202(12):1819-25. PubMed ID: 21050119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India.
    Dravid AN; Gawali R; Betha TP; Sharma AK; Medisetty M; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Letendre SL; Wadia RS; Calcagno A
    Medicine (Baltimore); 2020 Jun; 99(24):e20516. PubMed ID: 32541474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
    Edén A; Nilsson S; Hagberg L; Fuchs D; Zetterberg H; Svennerholm B; Gisslén M
    J Infect Dis; 2016 Dec; 214(12):1822-1825. PubMed ID: 27683820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.
    Mukerji SS; Misra V; Lorenz D; Cervantes-Arslanian AM; Lyons J; Chalkias S; Wurcel A; Burke D; Venna N; Morgello S; Koralnik IJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):246-255. PubMed ID: 28328546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy.
    Guha D; Misra V; Yin J; Gabuzda D
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.
    Trunfio M; Rugge W; Mighetto L; Vai D; Atzori C; Nigra M; Domini S; Borgogno E; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    AIDS; 2020 Nov; 34(13):1899-1906. PubMed ID: 32701580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.
    Dahl V; Lee E; Peterson J; Spudich SS; Leppla I; Sinclair E; Fuchs D; Palmer S; Price RW
    J Infect Dis; 2011 Dec; 204(12):1936-45. PubMed ID: 22021620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.